Page 226 - 2019_04-Haematologica-web

M.A. Pulsipher et al.
References
1. Gratwohl A, Baldomero H, Aljurf M, et al. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010; 303(16):1617-1624.
2. Passweg JR, Baldomero H, Bader P, et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant. 2016; 51(6):786-792.
3. Pulsipher MA, Chitphakdithai P, Logan BR, et al. Donor, recipient, and transplant char- acteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood. 2009;114(13):2606-2616.
4. Pulsipher MA, Chitphakdithai P, Logan BR, et al. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. Blood. 2013;121(1):197-206.
5. Pulsipher MA, Chitphakdithai P, Logan BR, et al. Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation. Blood. 2014;123(23):3655- 3663.
6. Lee MH, Jang JH, Min HJ, et al. Predictors of general discomfort, limitations in activi- ties of daily living and intention of a second donation in unrelated hematopoietic stem cell donation. Bone Marrow Transplant. 2017;52(2):258-263.
7. Holig K, Kramer M, Kroschinsky F, et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood. 2009;114(18):3757-3763.
8. Kodera Y, Yamamoto K, Harada M, et al. PBSC collection from family donors in Japan: a prospective survey. Bone Marrow Transplant. 2014;49(2):195-200.
9. Lown RN, Philippe J, Navarro W, et al. Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee. Bone Marrow Transplant. 2014;49(7):880-886.
10. NMDP Standards. Available at: https:// bethematch.org/workarea/downloadas- set.aspx?id=7711: National Marrow Donor Program; 2015.
11. Miller J. Hematopoietic Progenitor Cell Donation Evaluation. In: Wingard J, Gastineau DA, Leather H, Snyder DL, Szczepiorkowski ZM, eds. Hematopoietic Stem Cell Transplantation: A Handbood
For Clinicians. Bethesda, MD: AABB;
2015:93-108.
12. Miller JP, Perry EH, Price TH, et al.
Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program. Biol Blood Marrow Transplant. 2008;14(9 Suppl):29-36.
13. Pulsipher MA, Chitphakdithai P, Miller JP, et al. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009;113(15):3604-3611.
14. Switzer GE, Bruce J, Kiefer DM, et al. Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study. Biol Blood Marrow Transplant. 2017;23(1):165-171.
15. Switzer GE, Bruce J, Kiefer DM, et al. Health-Related Quality of Life among Pediatric Hematopoietic Stem Cell Donors. J Pediatr. 2016;178:164-170.
16. Switzer GE, Bruce J, Pastorek G, et al. Parent versus child donor perceptions of the bone marrow donation experience. Bone Marrow Transplant. 2017;52(9):1338- 1341.
17. Shaw BE, Ball L, Beksac M, et al. Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations. Bone Marrow Transplant. 2010;45(5):832-838.
18. van Walraven SM, Nicoloso-de Faveri G, Axdorph-Nygell UA, et al. Family donor care management: principles and recom- mendations. Bone Marrow Transplant. 2010;45(8):1269-1273.
19. O'Donnell PV, Pedersen TL, Confer DL, et al. Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States. Blood. 2010;115(24):5097-5101.
20. Anthias C, Shaw BE, Kiefer DM, et al. Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers. Biol Blood Marrow Transplant. 2016;22(3):520-527.
21. Shaw PJ, Kan F, Woo Ahn K, et al. Outcomes of pediatric bone marrow trans- plantation for leukemia and myelodyspla- sia using matched sibling, mismatched related, or matched unrelated donors. Blood. 2010;116(19):4007-4015.
22. Weisdorf DJ, Anasetti C, Antin JH, et al. Allogeneic bone marrow transplantation
for chronic myelogenous leukemia: com- parative analysis of unrelated versus matched sibling donor transplantation. Blood. 2002;99(6):1971-1977.
23. Hows JM, Passweg JR, Tichelli A, et al. Comparison of long-term outcomes after allogeneic hematopoietic stem cell trans- plantation from matched sibling and unre- lated donors. Bone Marrow Transplant. 2006;38(12):799-805.
24. Luznik L, O'Donnell PV, Symons HJ, et al. HLA-haploidentical bone marrow trans- plantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophos- phamide. Biol Blood Marrow Transplant. 2008;14(6):641-650.
25. Saber W, Opie S, Rizzo JD, et al. Outcomes after matched unrelated donor versus iden- tical sibling hematopoietic cell transplanta- tion in adults with acute myelogenous leukemia. Blood. 2012;119(17):3908-3916.
26. Majhail NS, Chitphakdithai P, Logan B, et al. Significant improvement in survival after unrelated donor hematopoietic cell transplantation in the recent era. Biol Blood Marrow Transplant. 2015;21(1):142-150.
27. Bashey A, Zhang X, Sizemore CA, et al. T- cell-replete HLA-haploidentical hematopoi- etic transplantation for hematologic malig- nancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol. 2013;31(10):1310-1316.
28. Worel N, Buser A, Greinix HT, et al. Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues. Biol Blood Marrow Transplant. 2015;21(12):2052-2060.
29. DiMartini A, Dew MA, Liu Q, et al. Social and Financial Outcomes of Living Liver Donation: A Prospective Investigation Within the Adult-to-Adult Living Donor Liver Transplantation Cohort Study 2 (A2ALL-2). Am J Transplant. 2017; 17(4):1081-1096.
30. Dew M, Boneysteele G, DiMartini A. Unrelated Donors. In: Steel J, ed. Living Donor Advocacy: An Evolving Role Within Transplantation. New York: Springer; 2014:149-167.
31. Simmons RG, Klein SD, Simmons RL. Gift of Life: The Social and Psychological Impact of Organ Transplantation. Am J Sociol. 1979;85(2):179-481.
854
haematologica | 2019; 104(4)